Related Experiment Video
Updated: Aug 23, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
The miR-17-92 cluster: Yin and Yang in human cancers
Wenyuan Zhao1, Ananya Gupta2, Janusz Krawczyk3
1Discipline of Pathology, Cancer Progression and Treatment Research Group, Lambe Institute for Translational Research, School of Medicine, University of Galway, Galway, Ireland.
Abstract:
MicroRNAs (miRNAs) are non-coding RNAs which modulate gene expression via multiple post-transcriptional mechanisms. They are involved in a variety of biological processes, including cell proliferation, metastasis, metabolism, tumorigenesis, and apoptosis. Dysregulation of miRNA expression has been implicated in human cancers, and they may also serve as biomarkers of disease progression and prognosis. The miR-17-92 cluster is one of the most widely studied miRNA clusters, which was initially reported as an oncogene, but was later reported to exhibit tumour suppressive effects in some human cancers. This review summarizes the recent progress and context-dependant role of this cluster in various cancers. We summarize the known mechanisms which regulate miR-17-92 expression and molecular pathways that are in turn controlled by it. We discuss examples where it acts as an oncogene or a tumour suppressor along with key targets affecting hallmarks of cancer. We discuss how cellular contexts regulate the biological effects of miR-17-92. The plausible mechanisms of its paradoxical roles are explained, and mechanisms are described that may contribute to cell fate regulation by miR-17-92. Further, we discuss recently developed strategies to target miR-17-92 cluster in human cancers. MiR-17-92 may serve as a potential biomarker for prognosis and response to therapy as well as a target for cancer prevention and therapeutics.
Insights
The miR-17-92 cluster, a microRNA (miRNA) regulator, shows dual roles in cancer, acting as both an oncogene and tumor suppressor. Understanding its context-dependent functions is key for developing novel cancer biomarkers and therapeutics.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- MicroRNAs (miRNAs) are key regulators of gene expression involved in critical cellular processes.
- Dysregulated miRNA expression is linked to human cancer development and progression.
- The miR-17-92 cluster is a well-studied miRNA group with reported oncogenic and tumor-suppressive roles.
Purpose of the Study:
- To review the recent advancements and context-dependent roles of the miR-17-92 cluster in various cancers.
- To summarize mechanisms regulating miR-17-92 expression and its downstream molecular pathways.
- To discuss its dual role as an oncogene and tumor suppressor, impacting cancer hallmarks.
Main Methods:
- Literature review of recent progress on miR-17-92 cluster in cancer.
- Analysis of regulatory mechanisms and molecular pathways controlled by miR-17-92.
- Discussion of cellular context-dependent effects and targeting strategies.
Main Results:
- The miR-17-92 cluster exhibits context-dependent oncogenic or tumor-suppressive functions in different cancers.
- Its expression is tightly regulated, and it impacts key cancer hallmarks through various targets.
- Cellular context significantly influences the biological effects of the miR-17-92 cluster.
Conclusions:
- The miR-17-92 cluster's paradoxical roles in cancer are explained by cellular context and regulatory mechanisms.
- It plays a role in cell fate regulation and can be targeted for cancer therapy.
- The miR-17-92 cluster holds potential as a prognostic biomarker and therapeutic target in human cancers.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

